首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Analysis of Accuracy Evaluation of Five Blood Glucose Monitoring Systems: The North American Comparator Trial
【2h】

Analysis of Accuracy Evaluation of Five Blood Glucose Monitoring Systems: The North American Comparator Trial

机译:分析五个血糖监测系统的准确性评估:北美比较器试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In an article in Journal of Diabetes Science and Technology, Halldorsdottir and coauthors examined the accuracy of five blood glucose monitoring systems (BGMSs) in a study sponsored by the manufacturer of the BGMS CONTOUR NEXT EZ (EZ) and found that this BGMS was the most accurate one. However, their findings must be viewed critically given that one of the BGMSs (ACCU-CHEK Aviva) was not compared against the reference measurement specified by its manufacturer, thus making it likely that it performed suboptimally. Also, the accuracy of the glucose-oxidase-based ONE TOUCH Ultra2 and TRUEtrack BGMS is likely to have been underestimated because of the expected low oxygen level in the glycolysed blood samples used to test the performance of these BGMSs under hypoglycemic conditions. In conclusion, although this study shows that EZ is an accurate BGMS, comparisons between this and other BGMSs should be interpreted with caution.
机译:在《糖尿病科学与技术杂志》上的一篇文章中,Halldorsdottir及其合作者在由BGMS CONTOUR NEXT EZ(EZ)制造商赞助的一项研究中检查了五个血糖监测系统(BGMS)的准确性,发现该BGMS是最准确的一个。但是,鉴于没有将BGMS之一(ACCU-CHEK Aviva)与其制造商指定的参考测量值进行比较,因此必须严格审视他们的发现,从而可能导致其性能欠佳。同样,基于葡萄糖氧化酶的ONE TOUCH Ultra2和TRUEtrack BGMS的准确性可能被低估了,因为用于低血糖条件下测试这些BGMS性能的糖化血样中预期的低氧水平。总之,尽管这项研究表明EZ是一种准确的BGMS,但应谨慎解释此BGMS与其他BGMS之间的比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号